Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Portfolio Pulse from
The Biden administration has announced the next 15 prescription drugs that will undergo price negotiations with Medicare, as part of the Inflation Reduction Act. This initiative aims to make expensive medications more affordable for seniors.
January 17, 2025 | 1:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Ironwood Pharmaceuticals' drug, Linzess, is included in the next round of Medicare price negotiations, which could impact its pricing and revenue.
Linzess, a product of Ironwood Pharmaceuticals, is included in the Medicare price negotiations. This could lead to reduced prices, impacting the company's revenue from this drug. The negotiations are part of the Inflation Reduction Act, which aims to lower drug costs for seniors.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80